Avantor (MEX:AVTR) ROC (Joel Greenblatt) %: 25.70% (As of Mar. 2026) — 26% Below Median


MEX:AVTR Avantor Inc MEX:AVTR
61 GF Score
Price MXN244.00
GF Value MXN433.05
! 4 Warning Signs
View Full Analysis

What is Avantor ROC (Joel Greenblatt) %?

Avantor MEX:AVTR 61 ROC (Joel Greenblatt) % is 25.70% as of Mar. 2026, which is 26% below its 10-year median of 34.69. GuruFocus rates MEX:AVTR with a GF Score™ of 61/100 and a GF Value™ of MXN433.05. The stock has 4 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Avantor ranks worse than 64.88% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Avantor's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 25.70%.

The historical rank and industry rank for Avantor's ROC (Joel Greenblatt) % or its related term are showing as below:

MEX:AVTR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -19.97   Med: 34.69   Max: 70.49
Current: -19.97

During the past 10 years, Avantor's highest ROC (Joel Greenblatt) % was 70.49%. The lowest was -19.97%. And the median was 34.69%.

MEX:AVTR's ROC (Joel Greenblatt) % is ranked worse than
64.88% of 840 companies
in the Medical Devices & Instruments industry
Industry Median: 4.24 vs MEX:AVTR: -19.97

Avantor's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Avantor  (MEX:AVTR) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Avantor ROC (Joel Greenblatt) % Related Terms


Avantor ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Avantor's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avantor ROC (Joel Greenblatt) % Chart

Avantor Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.50 68.32 38.50 78.29 -17.33

Avantor Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.92 31.99 -171.35 32.19 25.70

MEX:AVTR vs ATR, TFX, RGEN: ROC (Joel Greenblatt) % Comparison

For the Medical Instruments & Supplies subindustry, Avantor's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avantor ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avantor's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Avantor's ROC (Joel Greenblatt) % falls into.


MEX:AVTR
61GF Score
Avantor Inc MEX:AVTR
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avantor ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(19348.925 + 14732.264 + 3475.1) - (14206.497 + 0 + 10066.987)
=13282.805

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(19922.527 + 14611.897 + 3785.064) - (13832.884 + 0 + 10156.017)
=14330.587

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Avantor for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=7097.672/( ( (13806.771 + max(13282.805, 0)) + (13816.655 + max(14330.587, 0)) )/ 2 )
=7097.672/( ( 27089.576 + 28147.242 )/ 2 )
=7097.672/27618.409
=25.70 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 25.70% mean?
Avantor (MEX:AVTR) has a ROC (Joel Greenblatt) % of 25.70% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Avantor and its competitors. This is 26% below median its historical median of 34.69. According to the industry distribution chart, Avantor ranks #545 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 64.9%.
Is Avantor's ROC (Joel Greenblatt) % too high?
Avantor's current ROC (Joel Greenblatt) % of 25.70% is 26% below median its 10-year median of 34.69. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.24. Avantor's value of 25.70% is 506.1% above this industry median. Based on the distribution chart, Avantor ranks #545 out of 840 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avantor has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Avantor's ROC (Joel Greenblatt) % compare to ATR and TFX?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #545 out of 840 companies for ROC (Joel Greenblatt) %. This places Avantor in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.24. Avantor's value of 25.70% is 506.1% above this benchmark. While the company's 10-year median is 34.69 vs. the industry median of 4.24, Avantor has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.24, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avantor's current ROC (Joel Greenblatt) % of 25.70% is 506.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current ROC (Joel Greenblatt) % is 25.70%, which is 26% below median its own 10-year median of 34.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Avantor (MEX:AVTR) has a current ROC (Joel Greenblatt) % of 25.70%. The stock's GF Value™ is MXN433.05, compared to a current price of MXN244.00 — trading 43.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 25.70%, which is 26% below median its 10-year median of 34.69 and 506.1% above the Medical Devices & Instruments industry median of 4.24. Avantor's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Avantor (MEX:AVTR), the current ROC (Joel Greenblatt) % is 25.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avantor (MEX:AVTR) Overvalued in 2026?

Based on GuruFocus' analysis, Avantor stock appears to be undervalued. The current stock price of MXN244.00 is trading 43.7% below its estimated GF Value™ of MXN433.05.

Key valuation signals for MEX:AVTR:

  • ROC (Joel Greenblatt) %: 25.70% (26% below median its 10-year median of 34.69)
  • GF Value™: MXN433.05 vs. price of MXN244.00 (43.7% below fair value)
  • GF Score™: 61/100 with 4 warning signs
  • Industry Position: 506.1% above the Medical Devices & Instruments median (#545 of 840)

No single metric tells the full story. See the MEX:AVTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Avantor Business Description

Address 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, USA, 19087
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
61GF Score

Get the complete analysis for MEX:AVTR

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN244.00
Price
MXN433.05
GF Value